Gilbert + Tobin

Insurance Australia Limited has settled $4 billion action brought by Germany's Greensill Bank and its administrator ahead of a six-month trial against the insurer and others over the failure of the trade financier.

Saint Gobain-owned CSR has been ordered to produce monthly performance reports for four of its business units and its building products division, in a competition case by insulation distributor Consolidated Energy.

Star's former group general counsel has told a judge she should not have to pay a $1.1 million fine for breaching her directors duties because she has suffered “extra-curial detriment” that includes unemployment. 

Dexus has lost its case over the validity of a default notice issued by Melbourne Aiport's operator, with a judge saying the real estate asset manager breached the company's confidentiality and "irrevocably undermined" its relationship with fellow shareholders.

Heads may roll after a court on Friday rejected the evidence of key Dexus employees at trial over a breach of APAC's shareholder deed, in a ruling that revealed some insiders suspected the "embarassing blunder" would come back to bite.

A judge has ordered that the names of the funders who backed unsuccessful proceedings over the failed Pentridge Village development in Melbourne be handed over.

Saint Gobain-owned CSR has been ordered to hand over monthly performance reports for four business units and its building products division, in a misuse of market power case by insulation distributor Consolidated Energy.

US drug maker Cosette is appealing a judge’s decision not to disqualify himself from Mayne Pharma's lawsuit seeking damages over the termination of their $672 million if he is appointed to case manage the dispute. 

ASIC is seeking a $1.3 million fine against Star’s former CEO Matthias Bekier and a $1.1 million fine against ex-general counsel Paula Martin for breaching their duties by failing to warn the casino operator's board about money laundering risks. 

It ditched a planned $627 million union, now US drug maker Cosette must pay more than $13 million toward Mayne Pharma's costs of the legal fallout. Whether it owes the "substantial damages" Mayne is claiming is an issue for another day.